Social Media

Is It Time to Change the Vaccine Dialogue? Campaigns Present Opportunities for Pharma

Is It Time to Change the Vaccine Dialogue? Campaigns Present Opportunities for Pharma

While social media can be a tool for pharma to help educate the public, it has also become a forum for the public to express their views about pharma, and it's not always flattering, as evidenced by the recent antivaccine movement.

Bad ad watchdog slams Kardashian's social-media post

Bad ad watchdog slams Kardashian's social-media post

By

The FDA said Kim Kardashian West's promotion of morning-sickness pill Diclegis misbranded the product by understating its risks.

Healthcare reimagined: Fortner finesses McKesson's bold vision

Healthcare reimagined: Fortner finesses McKesson's bold vision

From evolving healthcare laws to social engagement, litigation crises to media relations, McKesson's PR chief is hands-on in efforts to enhance the brand's image.

Patients expect pharma will boost engagement

Patients expect pharma will boost engagement

By

The pharma business needs to take engagement far more seriously than it has in the past. At the same time, there are signs that the industry is finally acting with more urgency and even transparency.

Treato bolsters social-media insight

The consumer-insights firm said it's debuting a listening feature that will make it harder for pharma to ignore Twitter, Reddit and the other big social platforms.

Doximity expands professional reach

Its alliance with the Society of Hospital Medicine will expand the network's reach among medical professionals.

Pfizer's "Get Old" campaign gets youthful

Pfizer's "Get Old" campaign gets youthful

By

The three-year-old campaign's youthful tone evolves as its audience ages.

New bill seeks to spur FDA to form clearer social media rules

New bill seeks to spur FDA to form clearer social media rules

By

Rep. Billy Long introduced legislation that is meant to push the FDA to implement clearer guidelines for regulating drug product information on social media.

UCLA looks to Twitter for health trends

UCLA looks to Twitter for health trends

By

Researchers say Twitter could provide critical insight into health needs for hard-to-reach groups.

Hints from the pros: Social media done well requires risk

Hints from the pros: Social media done well requires risk

By

Successful social-media engagement is not about the perfect picture or a tightly controlled brand. Instead, panelists at the Hub Convene conference indicated it's a matter of letting the audience take hold

University develops program to turn social media into adverse drug reaction data

A group of computer science and engineering students at the Carlos III Universidad in Madrid used natural language processing techniques to translate social-media and forum posts into adverse drug reaction data.

MM&M's top reads of 2014

MM&M's top reads of 2014

A look at the content that grabbed most reader interest over the past year.

Mixed reaction to a health-centric Facebook feature

Mixed reaction to a health-centric Facebook feature

The ACLU is among those questioning the positives of the rumored healthcare effort.

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Researchers give FDA social media advice

Researchers give FDA social media advice

By

Researchers from Boston Children's Hospital, Harvard Medical School and Brigham and Women's Hospital are offering a bit of internet advice for the Food and Drug Administration: do more.

Facebook's clinical trial

The networking site's emotion experiment rankles some in the science and political communities.

Clinical researchers dip toe into social media

Clinical researchers dip toe into social media

By

Researchers are increasingly using social media to recruit patients, albeit oftentimes in an arms-length manner.

Study finds researchers are social-media shy

Study finds researchers are social-media shy

By

Researchers find worries about being misunderstood or mixed in with "junk" news are among the reasons academic researchers are keeping their data points out of the social media swirl. Researchers say this fear is at the expense of a faster way to make an impact on public policy.

Survey shows Pharma digitally failing patients

Survey shows Pharma digitally failing patients

By

A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.

Survey shows Pharma digitally failing patients

Survey shows Pharma digitally failing patients

By

A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.

OPDP slams Facebook page

OPDP slams Facebook page

By

The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.

OPDP slams Facebook page

OPDP slams Facebook page

By

The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.

Engaging mobile diabetes management

Engaging mobile diabetes management

By

A six-month pilot program at the University of Chicago improved glycemic control and engaged patients and HCPs through one key device: a mobile phone.

IMS researchers urge pharma to get social

IMS researchers urge pharma to get social

By

The latest IMS report shows that 50% of the top 50 pharma companies are not on social media. Executive Director Murray Aitken tells MM&M it is to pharma's detriment.

FDA eases rules on ads in social media

FDA eases rules on ads in social media

The draft guidance is mostly procedural, and more guidance is expected, but experts say it does include some long-awaited clarity for advertisers.

Nodding to bloggers, Lilly digitizes content

Nodding to bloggers, Lilly digitizes content

By

The move to digitize a series of books it co-created with Disney for kids with type 1 diabetes was spurred by a meeting with the online diabetes community.

Doximity plays matchmaker

Doximity plays matchmaker

By

The physician networking service rolled out a job-hunting service that brings the medical job search into the modern age and provides a revenue stream.

Doximity plays matchmaker

Doximity plays matchmaker

By

The physician networking service rolled out a job-hunting service that brings the medical job search into the modern age and provides a revenue stream.

NIH goes social on Reddit

People asked, experts answered.


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.